Concepedia

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

Thomas L Holland, Adit A. Ginde, Roger Paredes, Thomas A. Murray, Nicole Engen, Greg Grandits, Andrew M. Vekstein, Noel Ivey, Ahmad Mourad, Uriel Sandkovsky,

The Lancet Respiratory Medicine · 2022 · 128 citations · 34 references

DOIFull text

Open access

Concepts

References

34

A Simple Sequentially Rejective Multiple Test Procedure

Sture Holm · Scandinavian Journal of Statistics · 1979 · 21.8K citations

, , +8

A Proportional Hazards Model for the Subdistribution of a Competing Risk

Jason P. Fine · Journal of the American Statistical Association · 1999 · 13.6K citations

, , +15

Remdesivir for the Treatment of Covid-19 — Final Report

John H. Beigel, Kay M Tomashek, Lori E. Dodd et al. · New England Journal of Medicine · 2020 · 7.7K citations · Full text

, , +15

A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

The Annals of Statistics · 1988 · 5K citations · Full text

, , +15

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Elisabetta Cameroni, John E. Bowen, Laura E. Rosen et al. · Nature · 2021 · 1.2K citations · Full text

, , +14